GLIS3 polymorphism is linked to susceptibility to both T1D and T2D [25,26,27,28] as well as rare mutations also causing neonatal diabetes [29], demonstrating that expression variation can modify diabetes risk. Here, GLIS3 is linked to diabetes mellitus.